Medication Assisted Treatment
Back to Top
Buprenorphine Treatment in Medicaid: study finds the evidence doesn’t support rationing buprenorphine to save State money or ensure safety.
Extended Release Naltrexone (XR-NTX) for Alcohol Dependence: XR-NTX patients persisted longer with treatment than oral medication patients and had lower inpatient and ER costs.
Medication Assisted Alcohol Treatment: Patients who received medication had lower healthcare utilization and total costs than those who did not.
Medication Assisted Opioid Treatment: Patients with opioid dependence who received medications as part of their comprehensive treatment had lower inpatient hospital use and total costs than patients who did not receive medications.Alcoholism Medications & Healthcare Utilization: patients treated with an alcoholism medication had lower healthcare utilization than those that did not.
MOTHER Study: as opposed to methadone treatment, babies born to mothers treated with buprenorphine during pregnancy showed significantly fewer withdrawal symptoms and left the hospital more quickly
Buprenorphine-Naloxone Treatment for Opioid-Addicted Youth: Study by the Delaware Valley Node of the NIDA Clinical Trials Network shows significantly better outcomes for a group of young opioid-addicted patients receiving buprenorphine-naloxone (“BUP”), compared with a group receiving detoxification, with differences narrowing when the BUP group was tapered from the medication.
Behavioral
Treatments and Applications
Law
& Ethics
Center
on the Continuum of Care:
Monitoring
and Adapting Addiction Treatment
Center
for Policy Research and
Analysis
Parents Translational Research Center
Adolescents
Treatment
Research Solutions
Clinical
Trials Network
Projects-at-a-Glance
TRI Collaborators
Addiction
Severity Index (ASI)
Other
Assessment Instruments
Publications
Presentations
Archives
Training
Order
TRI Resources
Career
Opportunities
Contact
Us
Research
Briefs
Sign
up for E-Alerts